This episode unpacks the evolving world of medical device regulatory compliance. We explore crucial updates, including the FDA's QMSR Final Rule effective February 2026 and its alignment with ISO 13485:2016. We also cover diverse global frameworks, core compliance components like QMS and risk management, common challenges, and strategic approaches to ensure market success while prioritizing patient safety. Key Questions: • What is the significance of the FDA’s QMSR Final Rule for medical device manufacturers? • How does the QMSR align U.S. regulations with the international ISO 13485:2016 standard? • When will the FDA's QMSR Final Rule become effective? • What are the key differences in regulatory requirements between the US, EU, Japan, and other major markets? • What constitutes a robust Quality Management System (QMS) for medical devices? • How can manufacturers effectively manage risks according to ISO 14971? • What are the primary challenges in achieving and maintaining global medical device compliance? • What strategies can MedTech companies employ for proactive regulatory compliance? Ready to turn these insights into your competitive edge? Pure Global’s regulatory experts guide MedTech companies through every step of 30+ markets worldwide. Explore how we can accelerate your market entry at https://pureglobal.com or email [email protected] for tailored support.